MP87-15 RANDOMIZED PHASE 2 STUDY EVALUATING OPTIMAL SEQUENCING OF SIPULEUCEL-T AND ANDROGEN DEPRIVATION THERAPY (STAND) IN BIOCHEMICALLY RECURRENT PROSTATE CANCER: PRELIMINARY CLINICAL OUTCOMES

Overview

authors

Kibel, Adam
Drake, Charles
Adams, George
Karsh, Lawrence, MD, FACS, CPI
Elfiky, Aymen
Shore, Neal
Vogelzang, Nicholas
Corman, John
Tyler, Robert
Maher, Johnathan
DeVries, Todd
Sheikh, Nadeem
Antonarakis, Emmanuel

Publication Date

2015

webpage

http://dx.doi.org/10.1016/j.juro.2015.02.1960

published in

JOURNAL OF UROLOGY Journal

301 E Princeton St., Orlando, FL 32804 | FH.RAS@AdventHealth.com | 407-200-2901

The information on this website is not a substitute for examination, diagnosis, and medical care provided by a licensed and qualified health professional. Please consult your physician before undertaking any form of medical treatment and/or adopting any exercise program or dietary guidelines. If you think you may have a medical emergency, call your physician or 911 immediately. AdventHealth Research Institute reserves the right to add, remove or edit content on this page at its sole discretion.